B.T. Li

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Joshua K. Sabari, Giulia C. Leonardi, Catherine A. Shu et al. · Annals of Oncology · 2018 · 318 citations · Full text

Medicine, Cancer Biology, Oncology +17

COVID-19 in patients with lung cancer

Jie Luo, Hira Rizvi, Isabel R. Preeshagul et al. · Annals of Oncology · 2020 · 269 citations · Full text

Medicine, Infectious Diseases, Oncology +5

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium

B.T. Li, Filip Jankú, B. Jung et al. · Annals of Oncology · 2019 · 157 citations · Full text

Medicine, Molecular Biology, Oncology +17

Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours

Ramaswamy Govindan, Marwan Fakih, Timothy Price et al. · Annals of Oncology · 2019 · 41 citations · Full text

Medicine, Oncology, Pharmacology +12

1321MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic non–small cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02

B.T. Li, David Planchard, Kōichi Goto et al. · Annals of Oncology · 2023 · 37 citations · Full text

Medicine, Oncology, Pharmacology +12